Kevin Knopp Sells Shares of 908 Devices Inc. $MASS

Key Points

  • Kevin Knopp sold 40,535 shares of 908 Devices Inc. ($MASS) worth $370,489.90.
  • $MASS last traded around $8.98.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Kevin Knopp, President and CEO at 908 Devices Inc. ($MASS), sold 40,535 shares at an average price of $9.14, for a total transaction of $370,489.90. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

908 Devices Inc. Stock Down 16.3%

Shares of 908 Devices Inc. ($MASS) traded around $8.98 on Friday, down 16.3% for the day.

Last price$8.98
Market cap$441.03M
Forward P/E-35.57
Beta0.63
52-week low$5.03
52-week high$11.25
50-day MA$8.79
200-day MA$7.19
Current ratio2.67
Quick ratio2.29
Debt-to-equity0.03

908 Devices Inc. Earnings

EPS (ttm)-$0.93
Revenue (ttm)$60.84M
Revenue growth23.30%
Net margin-56.96%
Return on equity-24.95%
Next earningsNov 10, 2026

Analysts Set New Price Targets

Average target$13
High target$14
Low target$12
Analysts covering3

About 908 Devices Inc.

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

ExchangeNasdaqGM
SectorHealthcare
IndustryMedical Devices
HeadquartersBurlington, MA
CEODr. Kevin J. Knopp Ph.D.
Employees172

Get 908 Devices Inc. alerts

New 13F filings, insider trades, and analyst moves on $MASS, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.